In melanoma, BRAF mutations (mainly BRAF V600E) are found in 50% of melanoma BM, leading to a constitutive activation of the MAPK signaling pathway, promoting cellular growth, invasion, and metastasis (70). The gene discussed is BRAF; the disease is melanoma.